| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $907.0M | +1.4% |
| Cost of Revenue | $18.5M | -88.1% |
| Gross Profit | $841.5M | +13.9% |
| R&D Expense | $138.3M | -4.3% |
| SG&A Expense | $101.4M | -9.5% |
| Operating Income | $244.4M | +1722.6% |
| Pre-tax Income | $252.8M | +925.4% |
| Income Tax | $56.1M | +1422.2% |
| Net Income | $155.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.5M | -37.4% |
| Accounts Receivable | $41.9M | -5.2% |
| Current Assets | $282.9M | -27.7% |
| Total Assets | $661.9M | -19.7% |
| Current Liabilities | $100.5M | +8.0% |
| Long-term Debt | $0 | — |
| Total Liabilities | $287.7M | +1.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $295.3M | +15.6% |
| Capital Expenditures | $6.4M | -91.5% |
| Investing Cash Flow | -$29.3M | +59.8% |
| Financing Cash Flow | -$383.8M | -127.6% |
| Free Cash Flow | $288.9M | +60.2% |
| +643.4% |
| EPS (Basic) | $1.58 | +690.0% |
| EPS (Diluted) | $1.55 | +675.0% |
| Stockholders' Equity |
| $374.2M |
| -30.9% |